Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB – Get Free Report) was the target of a significant growth in short interest in March. As of March 15th, there was short interest totalling 4,600 shares, a growth of 39.4% from the February 29th total of 3,300 shares. Based on an average trading volume of 8,700 shares, the short-interest ratio […]